BioAge Labs, Inc. (BIOA): A Bull Case Theory

We came across a bullish thesis on BioAge Labs, Inc. (BIOA) on Substack by Ragnarok Research. In this article, we will summarize the bulls’ thesis on BIOA. BioAge Labs, Inc. (BIOA)'s share was trading at $3.87 as of April 17^th.

[caption id="attachment_1236781" align="aligncenter" width="768"] A biopharmaceutical laboratory with researchers at work analyzing complex molecules.[/caption]

BioAge Labs (BIOA) represents a classic "cigarette butt" investment—an overlooked and beaten-down company that still has a few valuable puffs left. Following the abrupt halt of its STRIDES Phase...